Skip to main content

JPMORGAN CHASE & CO

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in FULC

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$151,416
-$77,088 QoQ
Shares Held
41,371
+38.9% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 154 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 41% Shared 0% None 59%

Common Shares in FULC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,243 across 425 Biotechnology names. FULC ranks #252 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FULC

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $151,416 41,371
2026-03-31 $228,504 29,792
2025-12-31 $235,123 20,789
2025-09-30 $166,233 18,069
2025-06-30 $179,994 26,162
2025-03-31 $604,491 209,893
2024-12-31 $371,862 79,120
2024-09-30 $668,169 187,163
2024-06-30 $204,854 33,041
2024-03-31 $1,500,345 158,935
2023-12-31 $77,220 11,440
2023-09-30 $48,391 10,899
2023-06-30 $4,336 1,314
2023-03-31 $542,266 190,269
2022-12-31 $1,344,512 184,686
2022-09-30 $1,585,315 195,960
2022-06-30 $970,763 198,115
2022-03-31 $4,739,128 200,386
2021-12-31 $3,588,822 202,873
2021-09-30 $4,900,837 173,727
2021-06-30 $1,934,312 184,572
2021-03-31 $3,127,648 265,505
2020-12-31 $466,057 39,800
2020-09-30 $42,306 5,335
2020-06-30 $86,877 4,750
2020-03-31 $252,840 21,176